{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:24:27Z","timestamp":1793121867797,"version":"4.5.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:sec id=\"ab-hoi250050-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Rare monogenic variants linked to nonischemic dilated cardiomyopathy (DCM) are enriched among individuals with secondary cardiomyopathies, such as peripartum (PPCM), alcohol-induced (ACM), and cancer therapy\u2013related (CCM) cardiomyopathies. However, it remains unclear whether a polygenic predisposition to DCM also contributes to these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association of a DCM polygenic score with PPCM, ACM, and CCM, and to evaluate the contributions of monogenic and polygenic susceptibilities to these secondary cardiomyopathies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a retrospective genetic association analysis of data from the Mass General Brigham (MGB) Biobank (n\u2009=\u200942\u202f137, 2008-2025), with replication in the UK Biobank (n\u2009=\u2009295\u202f160, 2005-2010), FinnGen (n\u2009=\u2009417\u202f950, 2017-2025), and the Veterans Affairs Million Veteran Program (n\u2009=\u2009516\u202f066, 2011-2025). In MGB Biobank, medical records were reviewed to ascertain secondary cardiomyopathy cases and antecedent clinical risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>DCM polygenic risk score and DCM monogenic variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcomes were the association of the DCM polygenic risk score with PPCM, ACM, and CCM and the prevalence of monogenic variants and a high polygenic score among individuals with cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (SD) age in the MGB Biobank was 55.7 (17.0) years at enrollment, and 24\u202f551 (58.3%) were female. Across the 4 study cohorts, 3414 individuals with secondary cardiomyopathy were identified, including 70 with PPCM, 2281 with ACM, and 1063 with CCM. The DCM polygenic score was associated with PPCM (odds ratio [OR], 1.82 per SD; 95% CI, 1.43-2.30), ACM (OR, 1.56; 95% CI,1.34-1.82), and CCM (OR, 1.64; 95% CI,1.24-2.15) (all with\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Monogenic variants were enriched but present in 7 of 113 individuals with medical record\u2013reviewed cardiomyopathy in MGB, while 66 had a high polygenic score, which conferred an approximately 3-fold increased odds of cardiomyopathy. Most individuals with cardiomyopathy lacked antecedent clinical risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi250050-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, individuals with PPCM, ACM, and CCM were enriched for monogenic DCM variants and a high DCM polygenic score, suggesting a shared genetic susceptibility influenced by distinct environmental precipitants. These findings support a shared genetic architecture between secondary cardiomyopathies and DCM, although additional work with larger numbers of individuals with cardiomyopathy is needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.3248","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:00:44Z","timestamp":1759330844000},"page":"1138","source":"Crossref","is-referenced-by-count":9,"title":["Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy\u2013Related Cardiomyopathies"],"prefix":"10.1001","volume":"10","author":[{"given":"Dimitri J.","family":"Maamari","sequence":"first","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran J.","family":"Biddinger","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Operations Research and Financial Engineering, Princeton University, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Jurgens","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"R\u00e4m\u00f6","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zheng","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saketh P.","family":"Challa","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolphurs","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Gongora","sequence":"additional","affiliation":[{"name":"Cardiology Division, Montefiore Healthcare Network\/Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania"},{"name":"Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Tsao","sequence":"additional","affiliation":[{"name":"Palo Alto Veterans Institute for Research, Palo Alto Health Care System, Palo Alto, California"},{"name":"Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Arany","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Huffman","sequence":"additional","affiliation":[{"name":"Palo Alto Veterans Institute for Research, Palo Alto Health Care System, Palo Alto, California"},{"name":"Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akl C.","family":"Fahed","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Sarma","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas G.","family":"Neilan","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Cardiovascular Imaging Research Center, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Verve Therapeutics, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Aragam","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"hoi250050r1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1536\/ihj.18-729","article-title":"Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality.","volume":"60","author":"Isogai","year":"2019","journal-title":"Int Heart J"},{"issue":"11","key":"hoi250050r2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/clc.23067","article-title":"National trends in hospitalizations and outcomes in patients with alcoholic cardiomyopathy.","volume":"41","author":"Ram","year":"2018","journal-title":"Clin Cardiol"},{"issue":"23","key":"hoi250050r3","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2015.04.013","article-title":"Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort Study.","volume":"65","author":"Armstrong","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi250050r4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies.","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"issue":"20","key":"hoi250050r5","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","article-title":"Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.","volume":"121","author":"Morales","year":"2010","journal-title":"Circulation"},{"issue":"32","key":"hoi250050r6","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy.","volume":"35","author":"van Spaendonck-Zwarts","year":"2014","journal-title":"Eur Heart J"},{"issue":"20","key":"hoi250050r7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","article-title":"Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.","volume":"121","author":"van Spaendonck-Zwarts","year":"2010","journal-title":"Circulation"},{"issue":"20","key":"hoi250050r8","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity.","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi250050r9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy.","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"hoi250050r10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cardfail.2017.03.003","article-title":"Truncating titin (TTN) variants in chemotherapy-induced cardiomyopathy.","volume":"23","author":"Linschoten","year":"2017","journal-title":"J Card Fail"},{"issue":"19","key":"hoi250050r11","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and phenotypic landscape of peripartum cardiomyopathy.","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"hoi250050r12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","article-title":"A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.","volume":"35","author":"Meder","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi250050r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172995","article-title":"Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.","volume":"12","author":"Esslinger","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"hoi250050r14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.118.035774","article-title":"Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery.","volume":"139","author":"Aragam","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"hoi250050r15","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-020-15823-7","article-title":"Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy.","volume":"11","author":"Pirruccello","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"hoi250050r16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"issue":"20","key":"hoi250050r17","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/eurheartj\/ehab030","article-title":"Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.","volume":"42","author":"Garnier","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"hoi250050r18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy.","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"hoi250050r19","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1038\/s41588-024-01975-5","article-title":"Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience.","volume":"56","author":"Jurgens","year":"2024","journal-title":"Nat Genet"},{"issue":"12","key":"hoi250050r20","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1038\/s41588-024-01952-y","article-title":"Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy.","volume":"56","author":"Zheng","year":"2024","journal-title":"Nat Genet"},{"issue":"5","key":"hoi250050r21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.124.004558","article-title":"Polygenic Risk in Families With Dilated Cardiomyopathy.","volume":"17","author":"Thompson","year":"2024","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"hoi250050r22","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6020017","article-title":"Implementation of electronic consent at a biobank: an opportunity for precision medicine research.","volume":"6","author":"Boutin","year":"2016","journal-title":"J Pers Med"},{"issue":"1","key":"hoi250050r23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6010006","article-title":"The Information technology infrastructure for the Translational Genomics Core and the Partners Biobank at Partners Personalized Medicine.","volume":"6","author":"Boutin","year":"2016","journal-title":"J Pers Med"},{"issue":"1","key":"hoi250050r24","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6010002","article-title":"Building the Partners HealthCare Biobank at Partners Personalized Medicine: informed consent, return of research results, recruitment lessons and operational considerations.","volume":"6","author":"Karlson","year":"2016","journal-title":"J Pers Med"},{"issue":"7726","key":"hoi250050r25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"7944","key":"hoi250050r26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"3","key":"hoi250050r27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","article-title":"Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank.","volume":"54","author":"Jurgens","year":"2022","journal-title":"Nat Genet"},{"issue":"9","key":"hoi250050r28","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/s41588-024-01894-5","article-title":"Rare coding variant analysis for human diseases across biobanks and ancestries.","volume":"56","author":"Jurgens","year":"2024","journal-title":"Nat Genet"},{"issue":"9","key":"hoi250050r29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy.","volume":"32","author":"Villard","year":"2011","journal-title":"Eur Heart J"},{"key":"hoi250050r30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1479-5876-12-192","article-title":"The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation.","volume":"12","author":"Franaszczyk","year":"2014","journal-title":"J Transl Med"},{"issue":"2","key":"hoi250050r31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"issue":"4","key":"hoi250050r32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures.","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"hoi250050r33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy.","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"hoi250050r34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms.","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"hoi250050r35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaccao.2020.04.007","article-title":"Impact of cancer therapy-related cardiac dysfunction on risk of heart failure in pregnancy.","volume":"2","author":"Nolan","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"5","key":"hoi250050r36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2021.24674","article-title":"Prevalence and cumulative risk of familial idiopathic dilated cardiomyopathy.","volume":"327","author":"Huggins","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"hoi250050r37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2023.11970","article-title":"Genetic architecture of dilated cardiomyopathy in individuals of African and European ancestry.","volume":"330","author":"Jordan","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"hoi250050r38","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.123.064847","article-title":"Rare variant genetics and dilated cardiomyopathy severity: the DCM Precision Medicine Study.","volume":"148","author":"Hofmeyer","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"hoi250050r39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease.","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"hoi250050r40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease.","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"issue":"20","key":"hoi250050r41","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1001\/jama.2023.7575","article-title":"Coronary artery calcium score and polygenic risk score for the prediction of coronary heart disease events.","volume":"329","author":"Khan","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"hoi250050r42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cardfail.2020.12.022","article-title":"Risk prediction for peripartum cardiomyopathy in delivering mothers: a validated risk model: PPCM risk prediction model.","volume":"27","author":"Davis","year":"2021","journal-title":"J Card Fail"},{"issue":"1","key":"hoi250050r43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000472","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.","volume":"3","author":"Ezaz","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"hoi250050r44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3747\/co.24.3349","article-title":"Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population.","volume":"24","author":"Rushton","year":"2017","journal-title":"Curr Oncol"},{"issue":"3","key":"hoi250050r45","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/jcm11030847","article-title":"Evaluation of risk prediction models to identify cancer therapeutics related cardiac dysfunction in women with HER2+ breast cancer.","volume":"11","author":"Suntheralingam","year":"2022","journal-title":"J Clin Med"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2839098\/jamacardiology_maamari_2025_oi_250050_1762209216.53577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:01:41Z","timestamp":1762963301000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2839098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.3248","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}